Chronic inflammation is one of the main features of cancer cachexia. Experimental and
clinical studies showed that cyclooxygenase-2 inhibitors, such as celecoxib, may be …

Tumourigenesis is a relatively common event in endocrine tissues. Currently, specific
guidelines have been developed for common malignant endocrine tumours, which also …

Fairly advanced clinical data on efficacy of cyclooxygenase-2 inhibitors and antioxidants in
advanced cancer patients are promising, but the best way to administer and combine them …

Cancer cachexia is a multifactorial condition that contributes to the death of about 20% of
cancer patients. It has the potential to cause weight loss, reduction in muscle mass, and loss …

Background: Dietary supplementation with leucine and fish oil rich in omega-3 fatty acids
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) has previously been shown …

Objectives In oral squamous cell carcinoma (OSCC), cyclooxygenases (COX-1 and COX-2)
contribute to inflammation, and cluster of differentiation factor 147 (CD147) contributes to …

Progress made in the palliation of those with terminal cancers has allowed most symptoms
to be controlled if not completely alleviated. For many in this situation now, the most …

En el síndrome caquexia-anorexia-cáncer (Sx CAC) hay una incrementada demanda
calórica, expresión de sustancias anorexigénicas endógenas, cambios hormonales y …